Haemonetics Corporation Market Cap ($2.43 Billion)
Market Cap & Net Worth: Haemonetics Corporation (HAE)
Haemonetics Corporation market cap. Haemonetics Corporation (NYSE:HAE) has a market capitalization of $2.43 Billion ($2.43 Billion) as of November 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #5320 globally and #1792 in its home market, demonstrating a 3.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haemonetics Corporation's stock price $119.65 by its total outstanding shares 46471350 (46.47 Million). Also see HAE cash flow conversion for how efficiently the company converts equity into cash flow.
Haemonetics Corporation Market Cap History (2015–2026)
Haemonetics Corporation market cap history from 2015 to 2026. Data shows growth from $1.50 Billion to $5.56 Billion (12.63% CAGR). Check HAE share price today for real-time trading data and today's change.
Index Memberships
Haemonetics Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.34 Trillion | 0.12% | #368 of 401 |
Weight: Haemonetics Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Haemonetics Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haemonetics Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HAE year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.17x
Haemonetics Corporation's market cap is 4.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
57.14x
Haemonetics Corporation's market cap is 57.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.70 Billion | $886.12 Million | -$26.27 Million | 3.05x | N/A |
| 2018 | $4.65 Billion | $903.92 Million | $45.57 Million | 5.14x | 102.02x |
| 2019 | $5.34 Billion | $967.58 Million | $55.02 Million | 5.52x | 97.05x |
| 2020 | $5.52 Billion | $988.48 Million | $76.53 Million | 5.58x | 72.11x |
| 2021 | $2.46 Billion | $870.46 Million | $79.47 Million | 2.83x | 31.02x |
| 2022 | $3.65 Billion | $993.20 Million | $43.38 Million | 3.68x | 84.26x |
| 2023 | $3.97 Billion | $1.17 Billion | $115.40 Million | 3.40x | 34.43x |
| 2024 | $3.63 Billion | $1.31 Billion | $117.56 Million | 2.77x | 30.87x |
| 2025 | $3.72 Billion | $1.36 Billion | $167.68 Million | 2.74x | 22.21x |
| 2026 | $5.56 Billion | $1.33 Billion | $97.31 Million | 4.17x | 57.14x |
Competitor Companies of HAE by Market Capitalization
Companies near Haemonetics Corporation in the global market cap rankings as of November 1, 2026. Also see Haemonetics Corporation assets under control for a full breakdown of the balance sheet.
Key companies related to Haemonetics Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Haemonetics Corporation (2015–2026)
Market capitalization of Haemonetics Corporation from 2015 to today. Between 2015 and today, Haemonetics Corporation's market cap moved from $1.50 Billion to $ 5.56 Billion, with a yearly change of 12.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.56 Billion | +49.28% |
| 2025 | $3.72 Billion | +2.65% |
| 2024 | $3.63 Billion | -8.69% |
| 2023 | $3.97 Billion | +8.72% |
| 2022 | $3.65 Billion | +48.28% |
| 2021 | $2.46 Billion | -55.33% |
| 2020 | $5.52 Billion | +3.35% |
| 2019 | $5.34 Billion | +14.84% |
| 2018 | $4.65 Billion | +72.26% |
| 2017 | $2.70 Billion | +44.48% |
| 2016 | $1.87 Billion | +24.69% |
| 2015 | $1.50 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Haemonetics Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.43 Billion USD |
| MoneyControl | $2.43 Billion USD |
| MarketWatch | $2.43 Billion USD |
| marketcap.company | $2.43 Billion USD |
| Reuters | $2.43 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more